dosage of semaglutide for weight loss Dosing Guide (2026): Doses, Chart & Max Maximizing Semaglutide: Understanding the Doses

PATIENTS with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S

Your provider should discuss whether your current treatment plan needs adjustment, what additional interventions might help, and how to prevent further progression

We focus on a telehealth-first approach, meaning you can consult with specialists from your home to adjust your program as your needs change

Although they are a diverse group, DPP4i are all small, orally available molecules that interact with the catalytic site of DPP4 without disturbing any of its other known functions, including its effects on the immune system